InvestorsHub Logo
Followers 553
Posts 8508
Boards Moderated 3
Alias Born 10/23/2016

Re: tchalla post# 23033

Saturday, 09/19/2020 1:37:35 PM

Saturday, September 19, 2020 1:37:35 PM

Post# of 200355
lol tchalla you said: “horrible misinformation. you are posting pr's about phase three "field trials" (whatever those are) for another pinksheet misfit company, immb. has nothing to do with enzc or bioclonetics.“

dat dont make no sense. YOU have posted so much FUD and misinformation.....its rather comical. : here....more reading and simple dd for you lol:


“Enzolytics currently holds a 49% Interest in Immunotech Laboratories BG-Europe. Immunotech BG-Europe has a license for the development and commercialization of Enzolytics Patented ITV-1 Technology. Immunotech BG-Europe , under the branded ImmunH , utilizing the technology has successfully completed Phase III clinical trials at the Specialized Hospital for Active Treatment of Infectious and Parasite Disease in Sofia, Bulgaria, specific for the treatment of HIV/AIDS.“


https://enzolytics.com/immunh-bg%2Feurope